Ab­b­Vie shares slide on slid­ing Hu­mi­ra rev­enue; Deer­field is mak­ing a big in­vest­ment in new de­vice star­tups

→ Ab­b­Vie trig­gered alarm bells on Wall Street to­day as the phar­ma com­pa­ny cit­ed biosim­i­lar com­pe­ti­tion in Eu­rope for a steep de­cline in ex­pect­ed Hu­mi­ra rev­enue. Shares $AB­BV dropped 7% on the news. Sales in Eu­rope are ex­pect­ed to drop 30% this year, though so far Ab­b­Vie has been able to re­tain mar­ket ex­clu­siv­i­ty for the mega-block­buster in the US for some years to come.

→ Deer­field Man­age­ment and Stan Rowe have cre­at­ed a new de­vice in­cu­ba­tor called NXT Bio­med­ical. The in­cu­ba­tor plans to in­vest up to $25 mil­lion over the next 5 years and Deer­field — a pro­lif­ic in­vestor — will al­lo­cate up to $250 mil­lion for 5 to 8 start­up com­pa­nies that emerge from the in­cu­ba­tor.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER